181 related articles for article (PubMed ID: 9550704)
1. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
Zörnig M; Hueber AO; Evan G
Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
[TBL] [Abstract][Full Text] [Related]
2. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
Newton K; Harris AW; Bath ML; Smith KG; Strasser A
EMBO J; 1998 Feb; 17(3):706-18. PubMed ID: 9450996
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
4. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
Newton K; Kurts C; Harris AW; Strasser A
Curr Biol; 2001 Feb; 11(4):273-6. PubMed ID: 11250157
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
[TBL] [Abstract][Full Text] [Related]
6. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.
Hueber AO; Zörnig M; Bernard AM; Chautan M; Evan G
J Biol Chem; 2000 Apr; 275(14):10453-62. PubMed ID: 10744735
[TBL] [Abstract][Full Text] [Related]
7. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
Newton K; Harris AW; Strasser A
EMBO J; 2000 Mar; 19(5):931-41. PubMed ID: 10698935
[TBL] [Abstract][Full Text] [Related]
8. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
Hueber AO; Bösser S; Zörnig M
Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
[TBL] [Abstract][Full Text] [Related]
9. A role for FADD in T cell activation and development.
Walsh CM; Wen BG; Chinnaiyan AM; O'Rourke K; Dixit VM; Hedrick SM
Immunity; 1998 Apr; 8(4):439-49. PubMed ID: 9586634
[TBL] [Abstract][Full Text] [Related]
10. Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis.
Zhang Y; Rosenberg S; Wang H; Imtiyaz HZ; Hou YJ; Zhang J
J Immunol; 2005 Sep; 175(5):3033-44. PubMed ID: 16116191
[TBL] [Abstract][Full Text] [Related]
11. The requirements for Fas-associated death domain signaling in mature T cell activation and survival.
Beisner DR; Chu IH; Arechiga AF; Hedrick SM; Walsh CM
J Immunol; 2003 Jul; 171(1):247-56. PubMed ID: 12817005
[TBL] [Abstract][Full Text] [Related]
12. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
[TBL] [Abstract][Full Text] [Related]
13. Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure.
Schuchmann M; Varfolomeev EE; Hermann F; Rueckert F; Strand D; Koehler H; Strand S; Lohse AW; Wallach D; Galle PR
Hepatology; 2003 Jan; 37(1):129-35. PubMed ID: 12500197
[TBL] [Abstract][Full Text] [Related]
14. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
15. T cell-specific FADD-deficient mice: FADD is required for early T cell development.
Kabra NH; Kang C; Hsing LC; Zhang J; Winoto A
Proc Natl Acad Sci U S A; 2001 May; 98(11):6307-12. PubMed ID: 11353862
[TBL] [Abstract][Full Text] [Related]
16. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.
Chinnaiyan AM; Tepper CG; Seldin MF; O'Rourke K; Kischkel FC; Hellbardt S; Krammer PH; Peter ME; Dixit VM
J Biol Chem; 1996 Mar; 271(9):4961-5. PubMed ID: 8617770
[TBL] [Abstract][Full Text] [Related]
17. FADD/MORT1, a signal transducer that can promote cell death or cell growth.
Strasser A; Newton K
Int J Biochem Cell Biol; 1999 May; 31(5):533-7. PubMed ID: 10399313
[TBL] [Abstract][Full Text] [Related]
18. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction.
Bang S; Jeong EJ; Kim IK; Jung YK; Kim KS
J Biol Chem; 2000 Nov; 275(46):36217-22. PubMed ID: 10952991
[TBL] [Abstract][Full Text] [Related]
19. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard.
Rosenthal DS; Velena A; Chou FP; Schlegel R; Ray R; Benton B; Anderson D; Smith WJ; Simbulan-Rosenthal CM
J Biol Chem; 2003 Mar; 278(10):8531-40. PubMed ID: 12482751
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.
Zhu N; Ware CF; Lai MM
Virology; 2001 May; 283(2):178-87. PubMed ID: 11336543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
